Petzer, A. L., Wolf, D., Fong, D., Lion, T., Dyagil, I., Masliak, Z., Bogdanovic, A., Griskevicius, L., Lejniece, S., Goranov, S., Gercheva, L., Stojanovic, A., Peytchev, D., Tzvetkov, N., Griniute, R., Oucheva, R., Ulmer, H., Kwakkelstein, M., Rancati, F. and Gastl, G. (2010) “High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 ‘ISTAHIT’ study”, Haematologica. Pavia, Italy, 95(6), pp. 908-913. doi: 10.3324/haematol.2009.013979.